(European Society of Cardiology) Survival and other cardiovascular outcomes were not significantly reduced with intensive treatment using a second-line cholesterol-lowering medication on top of a standard statin, compared to statin treatment alone in patients with acute coronary syndrome and dyslipidemia, investigators reported here.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2bv7yYH
No comments:
Post a Comment